B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.384 NOK 0.87%
Market Cap: 54.1m NOK

Wall Street
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
5.05 NOK
265% Upside
Average
Price Target
5.1 NOK
268% Upside
Highest
Price Target
5.25 NOK
279% Upside
Bergenbio ASA Competitors:
Price Targets
ORY
Oryzon Genomics SA
157% Upside
VNDA
Vanda Pharmaceuticals Inc
181% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
33% Upside
BIOPOR
Bioporto A/S
196% Upside
ZNTL
Zentalis Pharmaceuticals Inc
301% Upside
HPHA
Heidelberg Pharma AG
172% Upside
EXAS
Exact Sciences Corp
29% Upside
SWTX
SpringWorks Therapeutics Inc
14% Upside

Revenue
Forecast

Revenue Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGBIO's stock price target?
Price Target
5.1 NOK

According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Back to Top